Found: 5
Select item for more details and to access through your institution.
Meat consumption, ornithine decarboxylase gene polymorphism, and outcomes after colorectal cancer diagnosis.
- Published in:
- Journal of Carcinogenesis, 2012, v. 11, n. 1, p. 1, doi. 10.4103/1477-3163.104004
- By:
- Publication type:
- Article
ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Sustained Carbohydrate Antigen 19‐9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. 859, doi. 10.1634/theoncologist.2019-0878
- By:
- Publication type:
- Article
Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 4, p. 1052, doi. 10.1245/s10434-018-6334-8
- By:
- Publication type:
- Article
Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas.
- Published in:
- 2012
- By:
- Publication type:
- journal article